Our work provided new mechanistic insights for the inhibitory property of OTUD1 on the chemoresistance of NSCLC to erlotinib via suppression of YAP1 nuclear translocation and inactivation of the SOX9/SPP1 axis. Here, SOX9 is linked to non-small cell lung carcinoma.